Board of Directors
Nick is an experienced and successful bio-entrepreneur, well-known for building and leading the Solexa team that pioneered Next Generation Sequencing (NGS), technology that became the basis of Illumina’s current market-leading product line. Apart from his base in the UK, Nick has lived and worked in the USA, Japan and Belgium.
He acted as CEO of Pronota, interim COO of Cambridge Epigenetix, part-time CEO of Oxford Cancer Biomarkers and CEO of Solexa. Nick is currently CBO of DNA Electronics, a non-executive director of Bioventix PLC and a trustee of the Association of Medical Research Charities.